Biotechnology & Inventorship – What You Need To Know
Part 1: Inventorship Determinations: Disputes and Best Practices
Tuesday, September 19 2023
11:00 A.M – 12:15 P.M. (Pacific)
Virtual/B-CLE
General CLE Credit Available
Enroll here | Greenberg Traurig Biographies
Inventorship is the threshold determination for patent rights. As a result, individuals, research institutions, biotechnology start-ups, venture capitalists, and biopharma collaborators may face significant commercial implications from this determination, potentially with surprising (or even problematic) results.
In this three-part virtual series, BCLT & Greenberg Traurig discuss the law of biotechnology patent inventorship in patent prosecution, trade secret and patent litigation, and commercial transactions. The aim of this virtual speaker series is to educate biotechnology stake holders (scientists, entrepreneurs, funders, and their attorneys) on best practices for determining inventorship and addressing disputes, so that they may conduct their business affairs with greater certainty.
For anyone with a stake in a biotechnology invention, this series will help you optimize your rights and reduce your risks. Don’t miss it!
Schedule
Part 1: Inventorship Determinations: Disputes and Best Practices
Tuesday, September 19, 2023
11:00 A.M – 12:15 P.M. (Pacific)
In part one, Inventorship Determinations: Disputes and Best Practices, join BCLT Life Sciences Director Allison Schmitt in conversation with Brent Sokol, an experienced biotech litigator, and Micheal Hebert, a leading life science patent prosecutor. We discuss the legal standard for inventorship, provide case examples, and share best practices for determining inventorship and handling disputes during prosecution.
Part 2: Trade Secrets and Inventorship: Disputes and Best Practices
Tuesday, September 26, 2023
11:00 A.M – 12:15 P.M. (Pacific)
In part two, Trade Secrets and Inventorship: Disputes and Best Practices, join BCLT Life Sciences Director Allison Schmitt in conversation with Brent Sokol, an experienced biotech litigator, and Greg Bombard, a widely-recognized trade secret trial lawyer provide an overview of trade secret law. We recommend best practices for trade secret protection, and explore inventorship issues as they arise in the context of trade secret disputes.
Part 3: Transactions and Inventorship: Best Practices for Diligence and Covenants
Tuesday, October 3, 2023
11:00 A.M – 12:15 P.M. (Pacific)
In part three, Transactions and Inventorship: Best Practices for Diligence and Covenants, join BCLT Life Sciences Director Allison Schmitt in conversation with Brent Sokol, an experienced biotech litigator, and Prashant Girinath, a top life sciences patent strategist. We examine the law of inventorship, recommend best practices for transaction readiness and diligence, and provide case examples in which an inventorship dispute impacted a commercial transaction.
About B-CLE
- 2022 BCLT Advanced Life Sciences Institute
April 22, 2022
Agenda -
Carving out Induced Infringement: Update on Skinny Labels
April 6, 2022
12:00 – 1:00 PM PT
ResourcesSpeakers: Mila Owen(opens in a new tab), White & Case, and Allison Schmitt(opens in a new tab), BCLT
- Nov. 10, 2021: Berkeley Law AI Institute Panel on AI, Life Sciences and Healthcare (Moderator: Allison Schmitt; Panelists: Susan Tull (Latham & Watkins LLP), Andrea Wang (CEO, AHEAD Medicine), Vadim Nasarov (CEO, Immunomind))
- Nov. 10, 2021: BTLJ-CMTL-BCLT Symposium: Race & Technology Law: Innovating Health Equity.
o Panels on Promises of Technological Innovation & Its Equitable Distribution, and Equitable and Ethical Development of Novel Applied Technology & Potential for Misuse (co-moderated by Allison Schmitt)
o Fireside Chat with Dean Dayna Bowen Matthew (GW Law) on the Potential Application of Affordable Care Act § 1557 to Combat Structural Inequities in Healthcare (hosted by Allison Schmitt)
The Life Sciences Project explores issues central to understanding what drives innovation in the life sciences, including the factors affecting innovation in the pharmaceutical and healthcare spaces. Current topics include:
- Challenges with IP protection for life sciences inventions, including subject matter eligibility, written description and enablement, and application of trade secrets;
- Drug pricing and competition issues in the pharmaceutical industry;
- Comparative life science litigation and regulation issues related to pharmaceutical development worldwide;
- Emerging challenges with regulation and litigation on transformative life sciences technologies;
- IP protection and regulatory issues related to technologies that integrate life sciences and high technology, such as AI and digital health;
- Use of data in pharmaceutical and healthcare spaces, and the privacy issues arising from that use;
- Public health issues on a global level, including issues related to preparedness for future pandemics; and
- Promoting equity and justice in healthcare.
Allison Schmitt
Fellow and Director, BCLT Life Sciences Project
aaschmitt@berkeley.edu